Neutre
Johnson & Johnson proposes $5.5 billion talc settlement to end lawsuits
Ce briefing n’est pas encore disponible dans cette langue — version anglaise affichée.
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 76,000 lawsuits alleging that its talc products caused ovarian cancer. This move aims to conclude over a decade of litigation, contingent upon at least 95% of claimants' participation. The company plans an initial payment of up to $3 billion in 2027, with no further payments due until 2028.
Points clés
- Johnson & Johnson offers $5.5 billion to settle talc-related lawsuits.
- Settlement depends on 95% claimant participation; initial payment of up to $3 billion in 2027.
- Company aims to resolve decade-long litigation and focus on medical innovations.
Sources
- Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fightAssociated Press · July 28, 2026
- Johnson & Johnson pagará casi 5.000 millones en EE UU para zanjar las demandas del talco como causa de cáncerEl País · July 28, 2026
- Johnson & Johnson pagará cerca de 5.000 millones de euros para zanjar las demandas que vinculan su talco con el cáncerCadena SER · July 28, 2026
Généré par IA à partir de sources d'actualités publiques. Ceci n'est pas un conseil financier.
